User:Tizonacampeador2/sandbox
Neuritis | |
---|---|
![]() | |
Sciatic Nerve in acute polyneuritis (Top) and Ulnar nerve in polyneuritis leprosa (Bottom) | |
Specialty | Neurology |
Symptoms | Pain, Paresthesia, Paresis, Anesthesia, Paralysis |
Causes | Autoimmune disease, Infection, Physical injury, Paraneoplastic Syndrome |
Medication | Corticosteroids, Plasmapharesis, IVIG |
Neuritis (/njʊəˈraɪtɪs/) is inflammation of a nerve[1] or the general inflammation of the peripheral nervous system. Inflammation, and frequently concomitant demyelination[2][3][4], causes impaired conduction of neural signals and leads to aberrant nerve function. Neuritis is often conflated with neuropathy, a broad term describing any disease process which affects the peripheral nervous system. However, neuropathies may be due to either inflammatory[5] or non-inflammatory etiologies[6], and the term encompasses any form of damage, degeneration, or dysfunction, while neuritis refers specifically to the inflammatory process.
As inflammation is a common reaction to biological insult, many conditions may present with features of neuritis. Common causes include autoimmune diseases, such as multiple sclerosis; infection, either bacterial, such as leprosy, or viral, such as varicella zoster; post-infectious immune reactions, such as Guillain-Barre syndrome; or a response to physical injury, as frequently seen in siatica[7][8].
While any nerve in the body may undergo inflammation[9], specific etiologies may preferentially affect specific nerves[10]. The nature of symptoms depends on the specific nerves involved, neuritis in a sensory nerve may cause pain, paresthesia (pins-and-needles), hypoesthesia (numbness), and anesthesia, and neuritis in a motor nerve may cause paresis (weakness), fasiculation, paralysis, or muscle wasting.
Treatment centers around removing or managing any inciting cause of inflammation, followed by supportive care and anti-inflammatory or immune modulatory treatments.
Causes
[edit]Infection
Both active infections and post-infectious autoimmune processes cause neuritis[11]. Rapid identification of an infectious cause of neuritis dictates treatment approach and often has a much more positive long term prognosis than other etiologies[5]. Bacterial, viral, and spirochete infections all have been associated with inflammatory neural responses. Some of the bacterial agents most associated with neuritis are leprosy, lyme disease, and diphtheria. Viral causes of neuritis include herpes simplex virus, varicella zoster virus, and HIV.
Leprosy is frequently characterized by direct neural infection by the causative organism, mycobacterium leprae[12]. Leprosy presents with a heterogeneous clinical picture dictated by bacterial titer and inborn host resistance[5]. Tuberculoid leprosy, seen in cases where host immunity is high, is not commonly associated with neuritis. It presents with a low number of anesthetic, anhydrotic skin plaques with few bacilli, the result of a granulomatous process which destroys cutaneous nerves[13]. Lepromatous leprosy, seen when the host lacks resistance to the organism, presents with widespread skin lesions and palpably enlarged nerves[13]. Disease involvement in this form of leprosy characteristically progresses from cooler regions of the body, such as the tip of the nose and ear lobes, towards warmer regions of the body eventually resulting in extensive loss of sensation and destructive skin lesions. Rapid treatment is a critical component of care in patients affected with leprosy, delayed care results in permanent loss of sensation and tissue damage which requires an extensive treatment regime[14].
Lyme disease, caused by the spirochete Borrelia burgdorferi, is a tick-borne illness with both peripheral and central neurological manifestations. The first stage of Lyme disease frequently presents with a pathognomonic "bull's eye" rash, erythema migrans, as well as fever, malaise, and arthralgias. Roughly 15% of untreated patients will then develop neurological manifestations, classically characterized by cranial neuropathy, radiculoneuritis, and a lymphocytic meningitis[14]. The nerve inflammation seen in neurological lyme disease is associated with a lymphoctyic infiltrate without evidence of direct infection of peripheral nerves[13]. While commonly self-limiting, treatment with antibiotics may hasten resolution of symptoms[15][16].
Diptheria, a once common childhood respiratory infection, produces a neurotoxin which can result in a biphasic neuropathy[14]. This neuropathy begins with paralysis and numbness of the soft palate and pharynx as well as bulbar weakness several days to weeks after the initial upper respiratory infection, followed by an ascending flaccid paralysis caused by an acute inflammatory demyelinating neuropathy after several more weeks[13]. While antibiotics are effective at eradicating the bacterium, neurological sequelae of infection must be treated with diptheria antitoxin[17].
Herpes simplex virus is a common virus which latently resides in neuronal ganglia between active infections. HSV-1 commonly resides in cranial nerve ganglia, particularly the trigeminal ganglia, and may cause painful neuralgias during active periods. It has also been associated with Bell's palsy. HSV-2 frequently lies within lumbosacral ganglia and is associated with radiculopathies during active infection[14]. Herpes reactivation is often treated with acyclovir, although evidence for its efficacy in controlling peripheral neurological manifestation of disease remain poor[18].
Varicella zoster virus, the cause of chickenpox, can be found dormant throughout the nervous system after an initial infection. Reactivation of the virus cause herpes zoster, commonly known as shingles, is seen in a dematomal or cranial nerve distribution corresponding to the ganglion in which the latent virus resided. After the herpetic rash resolves, an additional period of postherpatic neuralgia may persist for weeks to months[13]. Antiviral medications, including acyclovir, are effective at controlling viral reactivation. Management of ensuing neuropathic often requires further management possibly including gabapentin, amitriptyline, carbamazepine, or topical lidocaine[19].
HIV is associated with a broad range of neurological manifestations, both during acute infection and during the progression of the disease. During acute infection both direct peripheral nervous involvement, most commonly bilateral facial palsy, and an acute inflammatory demyelinating polyneuropathy (Guillian-Barré syndrome) have been reported. As the disease process progresses, diffuse infiltrative lymphocytosis syndrome may include a lymphocytic inflammation of peripheral nerves which results in a painful symmetric polyneuropathy. Immune dysfunction over the course of infection may also result in chronic inflammatory demyelinating polyneuropathy or vasculitis induced mononeuritis multiplex[20]. Identifying HIV-associated neuropathy is confounded by the neurotoxic nature of many of the antiretrovirals used to manage the disease, as a general rule HIV-associated neuropathy will improve with continued antiretroviral therapy while medicated associated neuropathy will worsen[13].
Autoimmune Disease
Chronic Inflammatory Demyelinating Polyneuropathy
Paraneoplastic
Several different malignancies, particularly small-cell lung cancer and Hodgkin lymphoma, are associated with a paraneoplastic neuritis. This carcinomatous polyneuropathy is associated with the presence of antibodies against onconeural antigen, Hu, Yo, amphiphysin, or CV2/CRMP5, which recognize and bind to both tumor cells and peripheral nervous system neurons[21]. This paraneoplastic syndrome may present as either a sensory neuropathy, affecting primarily the dorsal root ganglion, resulting in a progressive sensory loss associated with painful paresthesias of the upper limbs, or a mixed sensorimotor neuropathy which is also characterized by progressive weakness. Treatment of paraneoplastic syndromes aim for both elimination of tumor tissue via conventional oncologic approach as well as immunotherapy options such as steroids, plasmapheresis or IVIG[22].
Metabolic Causes
porphyria
Toxic Causes
Many classes of medication may have toxic effects on peripheral nerves, these iatrogenic neuropathies are an increasingly common form of neuritis. Broad categories of medications associated with toxic effects on nerves include: antineoplastic agents, antibiotics, immunosuppressants, and cardiac medications[23]. Management of these medication induced neuropathies center around discontinuation of the offending agents, although patients will frequently continue to worsen for several weeks after cessation of administration[24].
Diagnosis
[edit]The accurate diagnosis of a neuritis begins with a thorough physical exam to characterize and localize any symptoms to a specific nerve or distribution of nerves.
Specific Subtypes of Neuritis
[edit]References
[edit]- ^ "neuritis" at Dorland's Medical Dictionary
- ^ Pau, D; Al Zubidi, N; Yalamanchili, S; Plant, G T; Lee, A G (2011-07). "Optic neuritis". Eye. 25 (7): 833–842. doi:10.1038/eye.2011.81. ISSN 0950-222X. PMC 3178158. PMID 21527960.
{{cite journal}}
: Check date values in:|date=
(help)CS1 maint: PMC format (link) - ^ Chowdhury, D.; Arora, A. (2001-05). "Axonal Guillain-Barre syndrome: a critical review". Acta Neurologica Scandinavica. 103 (5): 267–277. doi:10.1034/j.1600-0404.2001.103005267.x. ISSN 0001-6314.
{{cite journal}}
: Check date values in:|date=
(help) - ^ Hughes, Richard AC; Lunn, Michael PT; Frost, Chris; van Schaik, Ivo N (2013-02-28), The Cochrane Collaboration (ed.), "Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews", Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd, pp. CD010369, doi:10.1002/14651858.cd010369, retrieved 2020-05-10
- ^ a b c "CHAPTER 88: INFLAMMATORY AND INFECTIOUS POLYNEUROPATHY". Neurological disorders : course and treatment. Brandt, Thomas, 1943- (2nd ed ed.). Amsterdam: Academic Press. 2003. ISBN 978-0-12-125831-3. OCLC 162571014.
{{cite book}}
:|edition=
has extra text (help)CS1 maint: others (link) - ^ "CHAPTER 89:
Noninflammatory Polyneuropathy". Neurological disorders : course and treatment. Brandt, Thomas, 1943- (2nd ed ed.). Amsterdam: Academic Press. 2003. ISBN 978-0-12-125831-3. OCLC 162571014.
{{cite book}}
:|edition=
has extra text (help); line feed character in|chapter=
at position 12 (help)CS1 maint: others (link) - ^ Martini, Rudolf; Willison, Hugh (2016-04). "Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?: Neuroinflammation in the Peripheral Nerve". Glia. 64 (4): 475–486. doi:10.1002/glia.22899. PMC 4832258. PMID 26250643.
{{cite journal}}
: Check date values in:|date=
(help)CS1 maint: PMC format (link) - ^ Baloh, Robert W. (Robert William), 1942-. Sciatica and chronic pain : past, present and future. Cham, Switzerland. ISBN 978-3-319-93904-9. OCLC 1048610895.
{{cite book}}
: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link) - ^ Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. (2003).
- ^ Al Khalili, Yasir; Jain, Sameer; DeCastro, Alexei (2020), "Brachial Neuritis", StatPearls, StatPearls Publishing, PMID 29763017, retrieved 2020-05-11
- ^ Hehir, Michael K.; Logigian, Eric L. (2014-10). "Infectious Neuropathies:". CONTINUUM: Lifelong Learning in Neurology. 20: 1274–1292. doi:10.1212/01.CON.0000455881.83803.a9. ISSN 1080-2371.
{{cite journal}}
: Check date values in:|date=
(help) - ^ "IAL Textbook of Leprosy". 2017. doi:10.5005/jp/books/12958.
{{cite journal}}
: Cite journal requires|journal=
(help) - ^ a b c d e f Kershen, Joshua; Sabin, Thomas (2007), "INFECTIVE NEUROPATHIES", Neurology and Clinical Neuroscience, Elsevier, pp. 1127–1140, doi:10.1016/b978-0-323-03354-1.50088-2, ISBN 978-0-323-03354-1, retrieved 2020-05-11
- ^ a b c d Saporta, Mario A.; Shy, Michael E. (2015), "Peripheral Neuropathies", Neurobiology of Brain Disorders, Elsevier, pp. 167–188, doi:10.1016/b978-0-12-398270-4.00012-4, ISBN 978-0-12-398270-4, retrieved 2020-05-11
- ^ Cunha, Burke A., editor. Tickborne infectious diseases : diagnosis and management. ISBN 978-0-8247-4648-3. OCLC 892787077.
{{cite book}}
:|last=
has generic name (help)CS1 maint: multiple names: authors list (link) - ^ Halperin, John J (2018-01-02). "Diagnosis and management of Lyme neuroborreliosis". Expert Review of Anti-infective Therapy. 16 (1): 5–11. doi:10.1080/14787210.2018.1417836. ISSN 1478-7210.
- ^ Sharma, Naresh Chand; Efstratiou, Androulla; Mokrousov, Igor; Mutreja, Ankur; Das, Bhabatosh; Ramamurthy, Thandavarayan (2019-12). "Diphtheria". Nature Reviews Disease Primers. 5 (1): 81. doi:10.1038/s41572-019-0131-y. ISSN 2056-676X.
{{cite journal}}
: Check date values in:|date=
(help) - ^ Taylor, Michael; Gerriets, Valerie (2020), "Acyclovir", StatPearls, StatPearls Publishing, PMID 31194337, retrieved 2020-05-11
- ^ Johnson, Robert W.; Alvarez-Pasquin, Marie-José; Bijl, Marc; Franco, Elisabetta; Gaillat, Jacques; Clara, João G.; Labetoulle, Marc; Michel, Jean-Pierre; Naldi, Luigi; Sanmarti, Luis S.; Weinke, Thomas (2015-07). "Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective". Therapeutic Advances in Vaccines. 3 (4): 109–120. doi:10.1177/2051013615599151. ISSN 2051-0136. PMC 4591524. PMID 26478818.
{{cite journal}}
: Check date values in:|date=
(help) - ^ Gabbai, Alberto Alain; Castelo, Adauto; Oliveira, Acary Souza Bulle (2013), "HIV peripheral neuropathy", Handbook of Clinical Neurology, vol. 115, Elsevier, pp. 515–529, doi:10.1016/b978-0-444-52902-2.00029-1, ISBN 978-0-444-52902-2, retrieved 2020-05-11
- ^ a b Lindsay, Kenneth W. (2011). "SECTION IV - LOCALISED NEUROLOGICAL DISEASE AND ITS MANAGEMENT C. PERIPHERAL NERVE AND MUSCLE". Neurology and neurosurgery illustrated. Churchill Livingstone. pp. Pages 429-487. ISBN 978-0-443-06957-4. OCLC 972843900.
- ^ Leypoldt, F.; Wandinger, K.-P. (2014-03). "Paraneoplastic neurological syndromes: Paraneoplastic neurological syndromes". Clinical & Experimental Immunology. 175 (3): 336–348. doi:10.1111/cei.12185. PMC 3927895. PMID 23937626.
{{cite journal}}
: Check date values in:|date=
(help)CS1 maint: PMC format (link) - ^ Morrison, Brett; Chaudhry, Vinay (2012-02). "Medication, Toxic, and Vitamin-Related Neuropathies:". CONTINUUM: Lifelong Learning in Neurology. 18: 139–160. doi:10.1212/01.CON.0000411565.49332.84. ISSN 1080-2371.
{{cite journal}}
: Check date values in:|date=
(help) - ^ Weimer, Louis H.; Anziska, Yaacov (2007), "METABOLIC, IMMUNE-MEDIATED, AND TOXIC NEUROPATHIES", Neurology and Clinical Neuroscience, Elsevier, pp. 1113–1126, doi:10.1016/b978-0-323-03354-1.50087-0, ISBN 978-0-323-03354-1, retrieved 2020-05-11